Key Takeaways
- Martin Makary was sworn in as commissioner on 28 March.
- The timing of the ceremony meant Makary was briefed on the plan to push Peter Marks out of the FDA before Marks resigned and did not stop it.
- The events may concern FDA stakeholders who hoped Makary would be a check on the Trump Administration's attempts to intervene at the FDA and advance policies that do not align with the best scientific evidence.
New US Food and Drug Administration Commissioner Martin Makary was sworn in 28 March, multiple sources told the Pink Sheet. And the timing was such that Makary was briefed on...
The news likely will concern industry and other agency stakeholders, including lawmakers, who were banking on Makary trying to keep politics and anti-vaccine sentiment from higher up in the Trump...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?